skip to content

Broker Views

Broker Forecast - RBC Capital Markets issues a broker note on Circassia Pharmaceuticals Plc Ord 0.08p

21 June 2016 09:50

RBC Capital Markets today downgrades its investment rating on Circassia Pharmaceuticals Plc Ord 0.08p (LON:CIR) to sector performer (from top pick) and cut its price target to 105p (from 430p).

Story provided by

Related Company: CIR

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.